Lineage Cell Therapeutics, Inc. (LCTX)
1.50
-0.08
(-5.06%)
USD |
NYAM |
Mar 18, 16:00
1.51
+0.01
(+0.67%)
After-Hours: 20:00
Lineage Cell Therapeutics EPS Diluted (Quarterly) : 0.0035 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 0.0381 |
| OptimizeRx Corp. | 0.259 |
| Nutex Health, Inc. | 1.62 |
| ProKidney Corp. | -0.122 |
| Prime Medicine, Inc. | -0.2553 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.892M |
| Revenue (Quarterly) | 6.608M |
| Total Expenses (Quarterly) | 5.757M |
| Enterprise Value | 290.93M |
| Gross Profit Margin (Quarterly) | 96.19% |
| Profit Margin (Quarterly) | 13.50% |
| Earnings Yield | -18.55% |
| Normalized Earnings Yield | -8.22 |